The Firm represented Apria, Inc. (“Apria”) in connection with its initial public offering of 8,625,000 shares of common stock (including shares sold pursuant to the underwriters’ full exercise of their over-allotment option) at a public offering price of $20 per share. The shares were sold by selling stockholders, accordingly Apria did not receive any proceeds in the offering. Apria’s common stock began trading on the Nasdaq Global Select Market under the ticker symbol “APR” on February 11, 2021.
Apria, a Blackstone portfolio company, is a leading provider of integrated home healthcare equipment and related services in the United States, providing home respiratory therapy, obstructive sleep apnea treatment and negative pressure wound therapy.
The Simpson Thacher team included Edgar Lewandowski, William Golden, Eva Kang, Elise Quinones and Pia Figuerola (Capital Markets); Paul Bolaji (M&A); Jeannine McSweeney, Gregory Grogan and Jason Fixelle (Executive Compensation and Employee Benefits); Jonathan Goldstein and Morgan Otway (Tax); James Rapp and Niyati Roy (Public Company Advisory Practice); and Daniel Kay, Christine Marshall and Michael Ratay (Credit).